A postdoctoral position at Rutgers Cancer Institute of New Jersey/Rutgers University (State University of New Jersey) is available. The research interest of the lab is to study the molecular mechanisms of tumor suppressors, metabolic reprogramming, tumor microenvironment shaping and cancer immunology in cancer (Some related publications: Blood: 2022; PMID: 35981499. Nature Metabolism: 2022, in press. JCI, 2020, 130:3253. NatureCommunications, 2021, 12:3371;8:1823; 5:5218; 4:2935; and 4:2996. Genes Dev, 30:1956; and 31: 1641. eLIFE, 4:e08401; 5:e10727; and 7:e34701. PNAS, 108(39):16259; and 107(16):7455); Mol Cell, 38(5):689. Cell Death Differ. 22(11):1824; and 21(11):1792-804). More information regarding the lab is available at: https://www.cinj.org/FengLab

Candidates with strong backgrounds and skills in molecular biology and/or cancer biology are welcome. Rutgers Cancer Institute of New Jersey/Rutgers University (New Brunswick campus) is a National Health Institute (NIH)/National Cancer Institute (NCI) designated comprehensive cancer center. Rutgers Cancer Institute of New Jersey offers a highly collaborative scientific and friendly environment as well as a competitive salary and benefit. The campus is about 45 minutes from New York City. 

Applicants should send a CV by email to: Professor Zhaohui Feng, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA. E-mail: fengzh@cinj.rutgers.edu